1. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes 
Robert L. Kormos, MD, Jeffrey J. Teuteberg, MD, Francis D. Pagani, MD, Stuart D. Russell, MD, Ranjit John, MD, Leslie W. Miller, MD, Todd Massey, MD, Carmelo A. Milano, MD, Nader Moazami, MD, Kartik S. Sundareswaran, PhD, David J. Farrar, PhD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 139, Issue 5, Pages (May 2010)
DOI: /j.jtcvs
Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Kaplan–Meier survival for patients with and without early RVF receiving the HeartMate II LVAD, which includes the need for RVADs or extended inotropic support for more than 14 days.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Relative risk ratios of univariate and multivariate predictors of RVF during LVAD support.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions